Tetanus, Diphtheria, and Pertussis Articles & Studies

Morbidity and Mortality Weekly Reports (MMWR)

Adolescent vaccination rates for protection against diseases including pertussis, meningococcal disease, and human papillomavirus (HPV)–associated cancers were discussed in the CDC's Morbidity and Mortality Weekly Report (MMWR) released July 31, 2015 "National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014". 64(29);784-792

CDC. Pertussis and Influenza Vaccination among Insured Pregnant Women, Wisconsin, 2013–2014, July 17, 2015 64(27);746-750
> This MMWR reports that "The percentage of women who received Tdap during pregnancy increased from 13.8% of women delivering during January 2013 (63.1% of whom received Tdap 2–13 weeks before delivery) to 51.0% of women delivering during March 2014 (90.9% of whom received Tdap 2–13 weeks before delivery). Among women delivering during November 2013–March 2014, 49.4% had received influenza vaccine during pregnancy."

CDC Tetanus, Diphtheria, Pertussis Vaccination Coverage Before, During, and After Pregnancy — 16 States and New York City, 2011. MMWR May 22, 2015:64(19);522-526

CDC Pertussis Epidemic- California 2014. MMWR. Dec. 5, 2014. 63 (48);1129-1132.

CDC Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012. MMWR. Feb. 22, 2013. 620 (07);131-135.

 Research Articles

 

Updated 7/12/16

This website is supported by an independent educational grant from Merck and an educational grant from Sanofi Pasteur U.S. 
ACOG does not allow companies to influence its programs, publications, or advocacy positions.